Advertisement

Topics

Vyxeos Liposome for Injection Okayed for Patients with Two Types of AML

05:50 EDT 4 Aug 2017 | PharmPro

Vyxeos represents the first new chemotherapy advance in more than 40 years for adults with certain types of poor-prognosis acute myeloid leukemia.
Contributed Author: 
U.S. Food & Drug Administration
Topics: 

Original Article: Vyxeos Liposome for Injection Okayed for Patients with Two Types of AML

NEXT ARTICLE

More From BioPortfolio on "Vyxeos Liposome for Injection Okayed for Patients with Two Types of AML"

Quick Search
Advertisement
 

Relevant Topics

Food
Food is any substance consumed to provide nutritional support for the body. It is usually of plant or animal origin, and contains essential nutrients, such as carbohydrates, fats, proteins, vitamins, or minerals. The substance is ingested by an organism ...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...